Montreal could be the setting of where some of the world’s most innovate brain cancer treatment is being developed.
ODS Medical is developing new surgical-guidance tools, like a laser-based probe, to improve accuracy in cancer surgical procedures, but mostly brain cancer. To do it, the startup is able to identify tissues with diffusely infiltrative cancer through sophisticated machine learning algorithms and a set of advanced optical techniques, such as Raman spectroscopy (RS), intrinsic fluorescence spectroscopy (IRS) and diffuse reflectance spectroscopy (DRS).
The enemy of ODS Medical (and anyone with brain cancer), are low-density, invasive cancer cells that are difficult to treat through current treatments.
According to ODS, its treatment can identify cancer cells that have invaded a normal brain with an accuracy of over 90 per cent.
“It allows us to do things we could never do before,” said cofounder Kevin Petrecca, chief of neurosurgery and the head of the brain cancer research group at the Montreal Neurological Institute.
Read more at : Full Article